winona semaglutide Wegovy (semaglutide) Injector 0.25 mg/0.5 mL (4-Pack) — Mountainside Medical GLP-1 Weight Loss Medication -

L-, 350 mg, 100 , Bioherba L -

However, practical experience suggests avoiding a large meal immediately before or after injection

Zeman, M

Long-acting GLP-1 receptor agonists (e.g., albiglutide [no longer commercially available in the US], dulaglutide, exenatide extended-release, liraglutide, semaglutide) induce marked reductions in fasting plasma glucose (by stimulating insulin secretion) and modest reductions in postprandial glucose, while short-acting GLP-1 receptor agonists (e.g., exenatide, lixisenatide), have less of an effect on fasting plasma glucose concentrations and more of an effect on reducing postprandial glucose concentrations (by slowing gastric emptying and inhibiting glucagon secretion)